RVVTFRevive Therapeutics Ltd.

About Revive Therapeutics Ltd. (RVVTF)

Revive Therapeutics Ltd. (RVVTF) is a Drug Manufacturers - Specialty & Generic company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the Pink tier.

Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various programs.

Products and services

Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various programs.

RVVTF key facts

Ticker symbol

RVVTF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

2012

Employees

4

Estimated market cap

$5.61M (as of Apr 10, 2025)

Shares outstanding

418,564,269

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Latest filing

Interim Financial Report (Dec 31, 2024)

Revive Therapeutics Ltd. leadership

• Michael Frank — CEO, President
• Carmelo Marrelli — CFO
• Hugh Ferreira — Consultant

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with R